VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

MODI'IN, Israel and NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) ("VBL"), today announced financial results for the first quarter ended March 31, 2023, and provided a corporate

Related Keywords

Israel ,Modiin ,Israel General ,Dror Harats ,Labs Inc ,Exchange Commission ,Vascular Biogenics Ltd ,Notable Labs ,Chief Executive Officer ,Predictive Precision Medicines Platform ,Registration Statement ,Aleph Farms ,First Quarter ,Biogenics Ltd ,Proposed Merger ,Proxy Statement ,Annual Report ,Securities Act ,Private Securities Litigation Reform Act ,Gefallene Big Techs ,Therapeutics ,Reports ,First ,Quarter ,023 ,Financial ,Results ,Rovides ,Business ,Update ,